NCT04568421View on ClinicalTrials.gov

Argentinian Registry of Patients With Rheumatic Diseases and COVID-19 Infection

CompletedOBSERVATIONAL
Enrollment

2,982

Participants

Timeline

Start Date

August 18, 2020

Primary Completion Date

December 31, 2022

Study Completion Date

December 31, 2022

Conditions
Rheumatic Diseases
Interventions
DRUG

Immunosuppressive Agents

Immunomodulatory and/or immunosuppressive drugs according to the indication of the treating physician

Trial Locations (1)

1022

Sociedad Argentina de Reumatología, Buenos Aires

All Listed Sponsors
lead

Sociedad Argentina de Reumatologia

OTHER

NCT04568421 - Argentinian Registry of Patients With Rheumatic Diseases and COVID-19 Infection | Biotech Hunter | Biotech Hunter